ATE271860T1 - Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit - Google Patents

Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Info

Publication number
ATE271860T1
ATE271860T1 AT00964272T AT00964272T ATE271860T1 AT E271860 T1 ATE271860 T1 AT E271860T1 AT 00964272 T AT00964272 T AT 00964272T AT 00964272 T AT00964272 T AT 00964272T AT E271860 T1 ATE271860 T1 AT E271860T1
Authority
AT
Austria
Prior art keywords
endometriosis
infertility
fertility
treatment
increase
Prior art date
Application number
AT00964272T
Other languages
English (en)
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Application granted granted Critical
Publication of ATE271860T1 publication Critical patent/ATE271860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT00964272T 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit ATE271860T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility

Publications (1)

Publication Number Publication Date
ATE271860T1 true ATE271860T1 (de) 2004-08-15

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964272T ATE271860T1 (de) 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Country Status (28)

Country Link
EP (1) EP1220667B1 (de)
JP (2) JP2003510354A (de)
KR (1) KR100738724B1 (de)
CN (1) CN1218694C (de)
AR (1) AR028487A1 (de)
AT (1) ATE271860T1 (de)
AU (1) AU780736B2 (de)
BR (1) BR0014548A (de)
CA (1) CA2385974C (de)
CO (1) CO5251423A1 (de)
DE (1) DE60012554T2 (de)
DK (1) DK1220667T3 (de)
ES (1) ES2223581T3 (de)
GE (1) GEP20043313B (de)
HK (1) HK1044120B (de)
HU (1) HU225990B1 (de)
IL (2) IL148784A0 (de)
MA (1) MA25501A1 (de)
MX (1) MXPA02003453A (de)
MY (1) MY129518A (de)
NO (1) NO329663B1 (de)
NZ (1) NZ518429A (de)
PE (1) PE20010742A1 (de)
PT (1) PT1220667E (de)
TR (1) TR200200899T2 (de)
TW (1) TWI280877B (de)
UA (1) UA74168C2 (de)
WO (1) WO2001024788A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (de) 2006-06-29 2008-01-02 Polichem S.A. Verwendung einer hydrophilen Matrix, die ein Polyacrylsäurederivat, einen Celluloseether und ein Zerfallsmittel enthält, für die Herstellung eines Medikamentes zur Behandlung weiblicher Genitalstörungen
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
SG10201504913UA (en) * 2010-03-22 2015-07-30 Repros Therapeutics Inc Compositions and methods for non-toxic delivery of antiprogestins
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
IN2014DN10548A (de) 2012-05-31 2015-08-21 Repros Therapeutics Inc
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
AU5068090A (en) * 1989-03-07 1990-09-13 Adeza Biomedical Corporation Endometriosis diagnosis methods and reagents
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
IL148784A (en) 2006-12-31
DE60012554D1 (de) 2004-09-02
PE20010742A1 (es) 2001-07-19
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
HK1044120A1 (en) 2002-10-11
CO5251423A1 (es) 2003-02-28
MY129518A (en) 2007-04-30
NO20021591L (no) 2002-05-28
HUP0203050A3 (en) 2006-02-28
MA25501A1 (fr) 2002-07-01
KR100738724B1 (ko) 2007-07-12
NZ518429A (en) 2004-02-27
PT1220667E (pt) 2004-11-30
DK1220667T3 (da) 2004-12-06
NO329663B1 (no) 2010-11-29
NO20021591D0 (no) 2002-04-04
EP1220667B1 (de) 2004-07-28
KR20020062285A (ko) 2002-07-25
CA2385974C (en) 2010-01-26
AR028487A1 (es) 2003-05-14
HU225990B1 (en) 2008-02-28
WO2001024788A3 (en) 2001-12-06
EP1220667A2 (de) 2002-07-10
MXPA02003453A (es) 2002-08-20
CN1377264A (zh) 2002-10-30
CA2385974A1 (en) 2001-04-12
BR0014548A (pt) 2002-06-04
GEP20043313B (en) 2004-03-10
ES2223581T3 (es) 2005-03-01
JP2003510354A (ja) 2003-03-18
HK1044120B (zh) 2004-12-17
TR200200899T2 (tr) 2002-07-22
AU780736B2 (en) 2005-04-14
IL148784A0 (en) 2002-09-12
WO2001024788A2 (en) 2001-04-12
DE60012554T2 (de) 2005-11-24
UA74168C2 (uk) 2005-11-15
CN1218694C (zh) 2005-09-14
HUP0203050A2 (hu) 2003-02-28
TWI280877B (en) 2007-05-11

Similar Documents

Publication Publication Date Title
ATE250575T1 (de) Ep4 rezeptor selektive agonisten zur behandlung der osteoporose
ATE279407T1 (de) Fsh mimetika zur behandlung von infertilität
DE60013009D1 (de) Vorrichtung zur Kupfer-Elektroplattierung mit der Möglichkeit einer thermischen Behandlung
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
DE60020820D1 (de) Thiadiazolyl-harnstoffe oder -thioharnstoffe zur antiviralen behandlung
DE69919893D1 (de) Vorrichtung zur behandlung der weitsichtigkeit oder anderer augenbeschwerden
ATE293610T1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69912972D1 (de) Antibiotische zusammensetzungen zur behandlung des auges
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
DE69819515D1 (de) Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
DE60032905D1 (de) Selektive iglur5 rezeptorantagonisten zur behandlung der migräne
ATE271860T1 (de) Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit
HUP0200912A2 (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction
DE60031790D1 (de) Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
DE59707096D1 (de) Haarbehandlungsmittel zur Festigung der Haare
MXPA03004303A (es) DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR.
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE59904802D1 (de) Vorrichtung zur Behandlung von Biomolekülen
ATE358483T1 (de) Selektive dopamin-d4-rezeptoragonisten zur behandlung von sexuellen dysfunktionen
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
NL1000553A1 (nl) Werkwijze voor de bereiding van polycarbonaat-polyisobuteen- blokcocondensaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220667

Country of ref document: EP